Multipl Skleroz Hastalarında Metilprednizolon ve İnterferon Tedavisinin Kan Vitamin B12, Folik Asid ve Homosistein Düzeyleri Üzerine Etkisi
Open Access
- 30 September 2019
- journal article
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 4 (3) , 325-338
Abstract
Changes in blood homocysteine, vitamin B12 and folic acid levels have been reported during multiple sclerosis (MS) and treatment period; however, the exact mechanism has not been enlightened. We investigated the changes of serum B12, folic acid, and plasma homocysteine levels before and after high-dose IV methylprednisolone treatment and after interferon-β treatment in patients admitted with an acute attack of MS.31 patients followed for clinically definite MS (8 male, 23 female) and 10 control individuals were included in the study. 20 patients were admitted with an acute attack and were administered 1000 mg/day methylprednisolone for 7 days. 27 patients started interferon-β treatment. Serum B12, folic acid, and plasma Homocysteine levels measured before and after the 1 month after high dose steroid treatment and after 3-month interferon-β treatment were compared with pre-treatment levels and healthy controls. Baseline B12 levels were lower in patients with MS than in healthy controls, which is consistent with previous findings. Both methylprednisolone and interferon-β treatments increased serum B12 and folic acid levels compared with baseline; however, only the increase following methylprednisolone treatment was statistically significant.In our study, elevated B12 and folic acid levels and decreasing of homocysteine levels without reaching statistical significance following methylprednisolone have caused different debates.Keywords
This publication has 23 references indexed in Scilit:
- Neuroimmunology2008
- Plasma homocysteine levels in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Vitamin B12, demyelination, remyelination and repair in multiple sclerosisJournal of the Neurological Sciences, 2005
- Lipoprotein Oxidation, Plasma Total Antioxidant Capacity and Homocysteine Level in Patients with Multiple SclerosisNutritional Neuroscience, 2003
- Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin‐4 production and associated eosinophiliaAnnals of Neurology, 1997
- Vitamin B12 Metabolism in Multiple SclerosisArchives of Neurology, 1992
- Multiple Sclerosis Associated With Vitamin B12 DeficiencyArchives of Neurology, 1991
- Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Observations on vitamin B12 in serum and cerebrospinal fluid in multiple sclerosisJournal of Clinical Pathology, 1965